Nektar Therapeutics Reports Second Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to Nektar Therapeutics Reports Second Quarter 2022 Financial Results
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 72.74 +0.99 (1.38%)
Previous Close $71.75    52 Week High $19.98 
Open $72.38    52 Week Low $10.52 
Day High $74.72    P/E N/A 
Day Low $70.70    EPS $-1.45 
Volume 348,034